26 min listen
Innovative Trial Design & Master Protocols: Lisa Lavange | Pod of Asclepius
Innovative Trial Design & Master Protocols: Lisa Lavange | Pod of Asclepius
ratings:
Length:
45 minutes
Released:
Sep 9, 2020
Format:
Podcast episode
Description
Lisa LaVange (Gillings School of Global Public Health at the University of North Carolina at Chapel Hill) was the 2018 American Statistical Association (ASA) president and the director of the Office of Biostatistics in the Center for Drug Evaluation and Research (CDER) at the FDA.
She give a high-level overview of issues surrounding Innovative Trial Design and Master Protocols. A great listen for anyone wanting to be introduced to the subject or (for those already familiar) interested in its growing breadth of applications.
#datascience #statistics #biopharm #pharma #FDA
She give a high-level overview of issues surrounding Innovative Trial Design and Master Protocols. A great listen for anyone wanting to be introduced to the subject or (for those already familiar) interested in its growing breadth of applications.
#datascience #statistics #biopharm #pharma #FDA
Released:
Sep 9, 2020
Format:
Podcast episode
Titles in the series (88)
S00 Ep03 Pt2 with Martin Ho and Greg Maislin: Bayesian Methods and Digital Health Initiatives: Part 2 of a three part episode with Martin Ho and Greg Maislin, talking about the ASA Section on Medical Devices and Diagnostics (MDD). This part discusses Bayesian Methods and Digital Health Initiatives. The other two parts of this episodes cover: Part... by Data & Science with Glen Wright Colopy